Cargando…
Caralluma fimbriata extract activity involves the 5‐HT2c receptor in PWS Snord116 deletion mouse model
INTRODUCTION: In Prader–Willi syndrome (PWS), nonprotein coding small nucleolar (sno) RNAs are involved in the paternally deleted region of chromosome 15q11.2‐q13, which is believed to cause the hyperphagic phenotype of PWS. Central to this is SnoRNA116. The supplement Caralluma fimbriata extract (C...
Autores principales: | Griggs, Joanne L., Mathai, Michael L., Sinnayah, Puspha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305914/ https://www.ncbi.nlm.nih.gov/pubmed/30353709 http://dx.doi.org/10.1002/brb3.1102 |
Ejemplares similares
-
Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome
por: Griggs, Joanne L., et al.
Publicado: (2015) -
Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract
por: Kamalakkannan, Soundararajan, et al.
Publicado: (2010) -
Single-Case Study of Appetite Control in Prader-Willi Syndrome, Over 12-Years by the Indian Extract Caralluma fimbriata
por: Griggs, Joanne
Publicado: (2019) -
Antihyperglycemic Activity of Caralluma fimbriata: An In vitro Approach
por: Ashwini, Shenai, et al.
Publicado: (2017) -
The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults
por: Rao, Amanda, et al.
Publicado: (2021)